Obamacare Rationing Begins

Brian Darling from RedState details the beginning of rationing based on the brave new world of Obamacare. Excerpt:

This past August, an advisory panel for the Food and Drug Administration recommended that the late stage cancer drug Avastin be “de-labeled” because of cost considerations. It is critical to note, the Food and Drug Administration (FDA) did not propose denying cancer victims the right to the drug because of the safety of the drug, but because of a formula containing cost as factor.

Senator David Vitter (R-LA) has taken a leadership position on the issue and has written letters to the FDA and expressing concern about “cost rationing.” Senator Vitter is worried that the Avastin case will be the beginning of ObamaCare rationing for drugs that may extend life. Rationing for seriously ill patients based on cost.

Should the FDA agree with the advisory panel’s recommendation, private insurers and Medicare will drop coverage for the drug for breast cancer patients, despite the fact that the drug extends life for an average of six months. This is a classic example of why many conservatives are concerned about government run health care.

Well, there's always bribery. Of course that's only for the well-to-do. So where does that leave us?